NVNOenVVeno Medical Corporation Common Stock
10.29USD-1.81%Mkt Cap: 7.03M $P/E: —4d ago
enVVeno Medical Corporation, a medical device company, focuses on the development of bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous disease in the United States. The compa…
Industry Peers
Medical Devices$203.22BUSDP/E 37.8
$125.74BUSDP/E 34.0
$118.91BUSDP/E 24.9
$71.03BUSDP/E 19.8
$48.43BUSDP/E 19.9
$52.11BUSDP/E 53.9
$34.85BUSDP/E 36.5
$34.04BUSDP/E 17.2
$25.08BUSDP/E 20.7
$26.90BUSDP/E 20.7
$23.19BUSDP/E 29.1
$19.26BUSDP/E 24.5
$12.75BUSDP/E 79.7
$12.40BUSDP/E 20.1
$11.29BUSDP/E 21.5
$10.95BUSD
$9.84BUSDP/E 20.0
$10.28BUSDP/E 27.5
$10.22BUSDP/E 46.5
$8.82BUSDP/E 25.0
| Headline | Source | Time |
|---|---|---|
Older | ||
 One enVVeno Medical Insider Raised Their Stake In The Previous Year Viewing insider transactions for enVVeno Medical Corporation's ( NASDAQ:NVNO ) over the last year, we see that insiders... | ||
Insider Buyers Lose Additional US$294k As enVVeno Medical Dips To US$6.5m The recent price decline of 22% in enVVeno Medical Corporation's ( NASDAQ:NVNO ) stock may have disappointed insiders... | ||
 NVNO's Shares Decline on Unfavorable FDA Review Outcome for VenoValve enVVeno Medical shares plunge after the FDA rejects its VenoValve PMA, citing insufficient trial data and safety concerns tied to the surgical procedure. | ||